138 related articles for article (PubMed ID: 8261818)
1. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
2. [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve].
Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):40-50. PubMed ID: 1851238
[TBL] [Abstract][Full Text] [Related]
3. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
[TBL] [Abstract][Full Text] [Related]
4. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
5. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve.
Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
Am J Gastroenterol; 1990 Sep; 85(9):1142-8. PubMed ID: 2389727
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
Pimstone NR; Stadalnik RC; Vera DR; Hutak DP; Trudeau WL
Hepatology; 1994 Oct; 20(4 Pt 1):917-23. PubMed ID: 7927233
[TBL] [Abstract][Full Text] [Related]
8. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
[TBL] [Abstract][Full Text] [Related]
9. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
10. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
11. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
13. Liver function in acute viral hepatitis as determined by a hepatocyte-specific ligand: 99mTc-galactosyl-neoglycoalbumin.
Virgolini I; Müller C; Höbart J; Scheithauer W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Hepatology; 1992 Apr; 15(4):593-8. PubMed ID: 1551636
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand Tc-99m-galactosyl-neoglycoalbumin--preclinical and clinical studies].
Kudo M; Todo A; Ikekubo K; Hino M; Ito H; Yamaguchi H; Saiki Y; Yamamoto K; Yonekura Y; Torizuka K
Kaku Igaku; 1987 Nov; 24(11):1653-62. PubMed ID: 3446908
[No Abstract] [Full Text] [Related]
15. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
Kurtaran A; Li SR; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
J Nucl Med; 1995 Oct; 36(10):1875-81. PubMed ID: 7562058
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
18. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage.
Kudo M; Todo A; Ikekubo K; Hino M
Am J Gastroenterol; 1992 Jul; 87(7):865-70. PubMed ID: 1615940
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Vera DR; Stadalnik RC; Krohn KA
J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the residual functional reserve and the early regeneration after the hepatic resection using asialoglycoprotein receptor imaging agent].
Toyama H; Ito K; Komori Y; Sugioka A; Shibata K; Komai S; Fujiwara T; Ishikawa E; Tomita K; Fujii N
Kaku Igaku; 1995 Mar; 32(3):323-9. PubMed ID: 7739162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
